SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients

Elise M. N. Ferré(National Institutes of Health), Michail S. Lionakis(National Institute of Allergy and Infectious Diseases)
Frontiers in Immunology
August 24, 2021
Cited by 25


Related Papers